Infertility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sperm tail anomaly
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Sperm mid-piece anomaly
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Absent sperm flagella
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Short sperm flagella
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Coiled sperm flagella
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Male infertility with teratozoospermia due to single gene mutation
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
SPERMATOGENIC FAILURE 33
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Tumor Cell Invasion
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
WDR66 expression is likely to play an important role in esophageal squamous cell carcinoma growth and invasion as a positive modulator of epithelial-mesenchymal transition.
|
23514407 |
2013 |
Malignant Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
WDR66 was identified to be required to maintain the EMT phenotype and the expression of cancer stem cell genes in the context of PTEN deficiency.
|
30569117 |
2019 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
WDR66 was identified to be required to maintain the EMT phenotype and the expression of cancer stem cell genes in the context of PTEN deficiency.
|
30569117 |
2019 |
Squamous cell carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A gene encoding WDR66, WD repeat-containing protein 66 was significantly highly expressed in esophageal squamous carcinoma specimens.
|
23514407 |
2013 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.
|
24026423 |
2014 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.
|
24026423 |
2014 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide association study identifies three loci associated with mean platelet volume.
|
19110211 |
2009 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association study identifies three loci associated with mean platelet volume.
|
19110211 |
2009 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium.
|
19820697 |
2009 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium.
|
19820697 |
2009 |
Male infertility
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
A Homozygous Ancestral SVA-Insertion-Mediated Deletion in WDR66 Induces Multiple Morphological Abnormalities of the Sperm Flagellum and Male Infertility.
|
30122540 |
2018 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A meta-analysis and genome-wide association study of platelet count and mean platelet volume in african americans.
|
22423221 |
2012 |
Adenoid Cystic Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Collectively, the results of the present study revealed a novel function of WDR66 in mediating the progression of PTEN‑deficient SACCs, thereby suggesting WDR66 inhibition to be a potential therapeutic approach towards successful management of SACC disease progression, particularly against tumors with decreased PTEN expression levels.
|
30569117 |
2019 |
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, knockdown of WDR66 decreased cellular proliferation, migration and invasion.
|
30569117 |
2019 |
Platelet mean volume determination (procedure)
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
GWAS and PheWAS of red blood cell components in a Northern Nevadan cohort.
|
31194788 |
2019 |
Osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, the present study proved that LINC00324 accelerated the proliferation and migration of osteosarcoma cells through regulating WDR66, providing a new prognostic target for osteosarcoma.
|
31225659 |
2020 |
Osteosarcoma of bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
In conclusion, the present study proved that LINC00324 accelerated the proliferation and migration of osteosarcoma cells through regulating WDR66, providing a new prognostic target for osteosarcoma.
|
31225659 |
2020 |